Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|April 3, 2021
Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell LinesEva Kiss, Gertrud Forika, Reka Mohacsi, et al.
Nuclear Medicine Communications|October 10, 2014
Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancerKornélia Kajáry, Tímea Tőkés, Magdolna Dank, et al.
Oncotargets and Therapy|July 8, 2021
Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2- Advanced Breast Cancer: A Nationwide Real-World ExperienceKatalin Boér, Gábor Rubovszky, György Rokszin, et al.
World Journal of Clinical Cases|September 2, 2022
Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancerZoltan Herold, Magdolna Herold, Julia Lohinszky, et al.
Frontiers in Oncology|November 19, 2019
Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing OncologistAttila M Szasz, Carrie Anne Minnaar, Gyongyver Szentmártoni, et al.
Biomedicines|March 28, 2024
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsGyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, et al.
Cancers|February 15, 2022
Longitudinal Analysis of 1α,25-dihidroxyvitamin D3 and Homocysteine Changes in Colorectal CancerDorottya Mühl, Magdolna Herold, Zoltan Herold, et al.
Pathology Oncology Research : POR|April 4, 2019
Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological CorrelationsKornélia Kajáry, Zsolt Lengyel, Anna-Mária Tőkés, et al.
Orvosi Hetilap|May 26, 2024
[Review of bone health in women receiving endocrine therapy because of breast cancer]Réka Kollár, Tamás Leel-Őssy, Veronika Pálffy, et al.
Journal of Clinical Medicine|August 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?Magdolna Dank, Dorottya Mühl, Magdolna Herold, et al.
Pageof 12